tiprankstipranks
Genedx Holdings Corp. (WGS)
NASDAQ:WGS
US Market
Want to see WGS full AI Analyst Report?

GeneDx Holdings (WGS) Blogger Opinions & Sentiment

978 Followers

Blogger Sentiment

Bullish: 70.00%
Sector Average
Bullish
WGS Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
100% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

GeneDx: Why I Think The Selloff Went Too Far
SeekingAlpha
GeneDx: Disappointing Q1 Creates Another Turnaround Opportunity
SeekingAlpha
GeneDx: The 50% Crash Creates A Compelling Entry
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of WGS?
Seeking Alpha’s Fernanda Galvez Jalil has a Bullish Sentiment.
    What do Motley Fool contributors think of WGS?
    Currently there's no blogger sentiment for WGS.
    What Is WGS’s Blogger Sentiment?
    WGS’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for WGS?
      The most recent blogger prediction for WGS was made by Fernanda Galvez Jalil, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          SPHRFStarpharma Holdings Limited
          PRRUFImmutep Ltd
          NURPFNeuren Pharmaceuticals Limited
          CLVLFClinuvel Pharmaceuticals